From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Tue, 25 Feb 2020 17:25:40 +0000

To: Gary Simon

Ce: Graham, Barney (NIH/VRC) [E];Ledgerwood, Julie (NIH/NIAID) [E];'Chen, Grace
(NIH/NIAID) [E]';Conrad, Patricia (NIH/NIAID) [E];Mascola, John (NIH/VRC) [E]

Subject: RE: Coronavirus vaccine

Thanks, Garry. | will pass your note on to the people who will be conducting the
phase 1 vaccine trial here at NIH.

Best regards,

Tony

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases

Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone:

FAX: (301) 496-4409

E-mail:f YF

The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

From: Gary Simon") G>

Sent: Tuesday, February 25, 2020 10:42 AM

To: Fauci, Anthony (NIH/NIAID) [€] [8 5); Fauci, Anthony (NIH/NIAID) [E]
EL (1)

Subject: Coronavirus vaccine

Dear Tony,

('m not sure which email you use.
S555 J Twrould certainly expedite getting

samples to NIH for immune assays.

 

gary

Gary L. Simon, MD, PhD, MACP
Walter G. Ross Professor of Medicine

NIH-001365
